235 related articles for article (PubMed ID: 9202565)
1. Intracavernosal drug-induced erection therapy versus external vacuum devices in the treatment of erectile dysfunction.
Soderdahl DW; Thrasher JB; Hansberry KL
Br J Urol; 1997 Jun; 79(6):952-7. PubMed ID: 9202565
[TBL] [Abstract][Full Text] [Related]
2. Intracavernosal therapy for erectile failure--impact of treatment and reasons for drop-out and dissatisfaction.
Purvis K; Egdetveit I; Christiansen E
Int J Impot Res; 1999 Oct; 11(5):287-99. PubMed ID: 10553808
[TBL] [Abstract][Full Text] [Related]
3. [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].
de Boer BJ; Lycklama a Nijeholt AA; Kleinjans HA
Ned Tijdschr Geneeskd; 2001 Apr; 145(16):783-7. PubMed ID: 11346917
[TBL] [Abstract][Full Text] [Related]
4. Comparison of long-term outcomes of penile prostheses and intracavernosal injection therapy.
Sexton WJ; Benedict JF; Jarow JP
J Urol; 1998 Mar; 159(3):811-5. PubMed ID: 9474156
[TBL] [Abstract][Full Text] [Related]
5. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
[TBL] [Abstract][Full Text] [Related]
6. Vacuum constriction devices: second-line conservative treatment for impotence.
Gilbert HW; Gingell JC
Br J Urol; 1992 Jul; 70(1):81-3. PubMed ID: 1638379
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction.
Kaplan SA; Reis RB; Kohn IJ; Shabsigh R; Te AE
Urology; 1998 Nov; 52(5):739-43. PubMed ID: 9801091
[TBL] [Abstract][Full Text] [Related]
8. The use of the vacuum erection device in the management of erectile impotence.
Earle CM; Seah M; Coulden SE; Stuckey BG; Keogh EJ
Int J Impot Res; 1996 Dec; 8(4):237-40. PubMed ID: 8981174
[TBL] [Abstract][Full Text] [Related]
9. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
Purvis K; Brekke I; Christiansen E
Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
[TBL] [Abstract][Full Text] [Related]
10. The external vacuum device in the management of erectile dysfunction.
Opsomer RJ; Wese FX; De Groote P; Van Cangh PJ
Acta Urol Belg; 1997 Dec; 65(4):13-6. PubMed ID: 9497591
[TBL] [Abstract][Full Text] [Related]
11. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
Vardi Y; Lidgi S; Moskovitz B; Levin RD
Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
[TBL] [Abstract][Full Text] [Related]
12. The value of a second injection on the pharmaco-induced erection test.
Pagani E; Puech-Leão P; Glina S; Reis JM
Int J Impot Res; 1997 Sep; 9(3):167-8. PubMed ID: 9315495
[TBL] [Abstract][Full Text] [Related]
13. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
Raina R; Lakin MM; Agarwal A; Ausmundson S; Montague DK; Zippe CD
Urology; 2004 Mar; 63(3):532-7; discussion 538. PubMed ID: 15028452
[TBL] [Abstract][Full Text] [Related]
14. Twelve-month comparison of two treatments for erectile dysfunction: self-injection versus external vacuum devices.
Turner LA; Althof SE; Levine SB; Bodner DR; Kursh ED; Resnick MI
Urology; 1992 Feb; 39(2):139-44. PubMed ID: 1736506
[TBL] [Abstract][Full Text] [Related]
15. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy.
Engel JD; McVary KT
Urology; 1998 May; 51(5):687-92. PubMed ID: 9610580
[TBL] [Abstract][Full Text] [Related]
16. Intracavernosal injection in the treatment of impotence: a prospective study of sexual, psychological, and marital functioning.
Althof SE; Turner LA; Levine SB; Risen C; Kursh ED; Bodner D; Resnick M
J Sex Marital Ther; 1987; 13(3):155-67. PubMed ID: 2444712
[TBL] [Abstract][Full Text] [Related]
17. Outcome of managing impotence in clinical practice.
Braatvedt GD
N Z Med J; 1999 Jul; 112(1092):272-4. PubMed ID: 10472891
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group.
Linet OI; Ogrinc FG
N Engl J Med; 1996 Apr; 334(14):873-7. PubMed ID: 8596569
[TBL] [Abstract][Full Text] [Related]
19. A simplified pharmacologic erection program for patients with spinal cord injury.
Zaslau S; Nicolis C; Galea G; Britanico J; Vapnek JM
J Spinal Cord Med; 1999; 22(4):303-7. PubMed ID: 10751135
[TBL] [Abstract][Full Text] [Related]
20. Patient satisfaction with pharmacologic erection program.
Hollander JB; Gonzalez J; Norman T
Urology; 1992 May; 39(5):439-41. PubMed ID: 1580034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
